‘Not Enough Time’ To Transfer All Marketing Authorizations In Case Of ‘No-Deal’ Brexit, says EFPIA
Executive Summary
A survey of EFPIA member companies has revealed some alarming statistics on the effects that a “no-deal” Brexit would have on trade, marketing authorizations, batch release and clinical trials.